Bangavax (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Bangavax" in English language version.

refsWebsite

Global rank English rank

6web.archive.org

1^st place

3dhakatribune.com

2,157^th place

1,278^th place

2doi.org

2^nd place

2thedailystar.net

593^rd place

395^th place

2nih.gov

4^th place

1daily-sun.com

7,477^th place

4,619^th place

1observerbd.com

low place

6,791^st place

1prothomalo.com

1,845^th place

2,414^th place

1arabnews.com

1,365^th place

928^th place

1semanticscholar.org

11^th place

8^th place

1com.bd

low place

1bdnews24.com

2,214^th place

1,775^th place

1newagebd.net

7,913^th place

4,651^st place

arabnews.com

Sumon S (8 January 2021). "Bangladesh joins global COVID-19 vaccine race with Bongavax set for clinical trial". Arab News. Archived from the original on 9 January 2021. Retrieved 28 April 2021.

bdnews24.com

Masum O (6 May 2021). "Bangavax first buzzed with hope, then fizzled". bdnews24.com. Archived from the original on 9 May 2021. Retrieved 6 May 2021.

com.bd

thefinancialexpress.com.bd

"Globe Biotech to produce vaccine candidate for clinical trial". The Financial Express. Dhaka. 6 January 2021. Retrieved 28 April 2021.

daily-sun.com

"Globe Biotech's Covid-19 vaccine 'BANCOVID' listed by WHO". Daily Sun. 17 October 2020. Archived from the original on 30 April 2021. Retrieved 28 April 2021.

dhakatribune.com

"Globe Biotech yet to get BMRC nod for human trials". Dhaka Tribune. 22 February 2021. Archived from the original on 29 April 2021. Retrieved 28 April 2021.
"Bangavax gets BMRC approval to start human trials". Dhaka Tribune. 23 November 2021. Retrieved 23 November 2021.
"Bangavax Covid vaccin: BMRC gives fresh conditions to Globe Biotech for human trials". Dhaka Tribune. 16 June 2021. Archived from the original on 28 June 2021. Retrieved 16 June 2021.

doi.org

Baray JC, Khan MM, Mahmud A, Islam MJ, Myti S, Ali MR, et al. (January 2020). "BANCOVID, the first D614G variant mRNA-based vaccine candidate against SARS-CoV-2 elicits neutralizing antibody and balanced cellular immune response". bioRxiv. doi:10.1101/2020.09.29.319061. S2CID 222127616.
Nag K, Baray JC, Khan MR, Mahmud A, Islam J, Myti S, et al. (18 May 2021). "An mRNA-based vaccine candidate against SARS-CoV-2 elicits stable immuno-response with single dose". Vaccine X. 39 (23): 3745–3755. doi:10.1016/j.vaccine.2021.05.035. PMC 8130517. PMID 34039497.

newagebd.net

"Global south moves towards vaccine sovereignty". New Age. 19 February 2022.

nih.gov

ncbi.nlm.nih.gov

Nag K, Baray JC, Khan MR, Mahmud A, Islam J, Myti S, et al. (18 May 2021). "An mRNA-based vaccine candidate against SARS-CoV-2 elicits stable immuno-response with single dose". Vaccine X. 39 (23): 3745–3755. doi:10.1016/j.vaccine.2021.05.035. PMC 8130517. PMID 34039497.

pubmed.ncbi.nlm.nih.gov

Nag K, Baray JC, Khan MR, Mahmud A, Islam J, Myti S, et al. (18 May 2021). "An mRNA-based vaccine candidate against SARS-CoV-2 elicits stable immuno-response with single dose". Vaccine X. 39 (23): 3745–3755. doi:10.1016/j.vaccine.2021.05.035. PMC 8130517. PMID 34039497.

observerbd.com

"'Bangavax' to get approval within a week". The Daily Observer. 25 April 2021. Retrieved 28 April 2021.

prothomalo.com

en.prothomalo.com

"Globe Biotech applies for clinical trial". Prothom Alo. 17 January 2021. Retrieved 28 April 2021.

semanticscholar.org

api.semanticscholar.org

Baray JC, Khan MM, Mahmud A, Islam MJ, Myti S, Ali MR, et al. (January 2020). "BANCOVID, the first D614G variant mRNA-based vaccine candidate against SARS-CoV-2 elicits neutralizing antibody and balanced cellular immune response". bioRxiv. doi:10.1101/2020.09.29.319061. S2CID 222127616.

thedailystar.net

"Bangavax gets ethical permission for human trial". The Daily Star. 23 November 2021. Retrieved 23 November 2021.
"3 Covid-19 vaccine candidates by Bangladesh's Globe Biotech enlisted in WHO draft landscape". The Daily Star. 17 October 2020. Archived from the original on 24 January 2021. Retrieved 4 May 2021.

web.archive.org

"Globe Biotech's Covid-19 vaccine 'BANCOVID' listed by WHO". Daily Sun. 17 October 2020. Archived from the original on 30 April 2021. Retrieved 28 April 2021.
"Globe Biotech yet to get BMRC nod for human trials". Dhaka Tribune. 22 February 2021. Archived from the original on 29 April 2021. Retrieved 28 April 2021.
Sumon S (8 January 2021). "Bangladesh joins global COVID-19 vaccine race with Bongavax set for clinical trial". Arab News. Archived from the original on 9 January 2021. Retrieved 28 April 2021.
"3 Covid-19 vaccine candidates by Bangladesh's Globe Biotech enlisted in WHO draft landscape". The Daily Star. 17 October 2020. Archived from the original on 24 January 2021. Retrieved 4 May 2021.
Masum O (6 May 2021). "Bangavax first buzzed with hope, then fizzled". bdnews24.com. Archived from the original on 9 May 2021. Retrieved 6 May 2021.
"Bangavax Covid vaccin: BMRC gives fresh conditions to Globe Biotech for human trials". Dhaka Tribune. 16 June 2021. Archived from the original on 28 June 2021. Retrieved 16 June 2021.